nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CHRM1—schizophrenia	0.541	0.728	CbGaD
Brompheniramine—CYP2D6—schizophrenia	0.202	0.272	CbGaD
Brompheniramine—CYP2C19—urine—schizophrenia	0.00348	0.0531	CbGeAlD
Brompheniramine—CYP2C9—urine—schizophrenia	0.0027	0.0412	CbGeAlD
Brompheniramine—CYP2E1—urine—schizophrenia	0.00256	0.039	CbGeAlD
Brompheniramine—CYP3A4—urine—schizophrenia	0.00206	0.0314	CbGeAlD
Brompheniramine—CYP2D6—urine—schizophrenia	0.00202	0.0309	CbGeAlD
Brompheniramine—CYP2C19—blood plasma—schizophrenia	0.00182	0.0277	CbGeAlD
Brompheniramine—CYP2C8—blood plasma—schizophrenia	0.00159	0.0242	CbGeAlD
Brompheniramine—CYP2B6—blood plasma—schizophrenia	0.00142	0.0217	CbGeAlD
Brompheniramine—CYP2C9—blood plasma—schizophrenia	0.00141	0.0215	CbGeAlD
Brompheniramine—CYP2E1—blood plasma—schizophrenia	0.00133	0.0204	CbGeAlD
Brompheniramine—CHRM4—nervous system—schizophrenia	0.00133	0.0203	CbGeAlD
Brompheniramine—CHRM2—forebrain—schizophrenia	0.00131	0.0201	CbGeAlD
Brompheniramine—CHRM4—central nervous system—schizophrenia	0.00128	0.0195	CbGeAlD
Brompheniramine—CHRM2—telencephalon—schizophrenia	0.00121	0.0184	CbGeAlD
Brompheniramine—CHRM1—forebrain—schizophrenia	0.0012	0.0183	CbGeAlD
Brompheniramine—CHRM1—telencephalon—schizophrenia	0.0011	0.0168	CbGeAlD
Brompheniramine—CYP3A4—blood plasma—schizophrenia	0.00107	0.0164	CbGeAlD
Brompheniramine—CHRM3—forebrain—schizophrenia	0.00107	0.0163	CbGeAlD
Brompheniramine—CYP2D6—blood plasma—schizophrenia	0.00106	0.0161	CbGeAlD
Brompheniramine—CHRM5—nervous system—schizophrenia	0.00104	0.0159	CbGeAlD
Brompheniramine—CHRM4—brain—schizophrenia	0.00102	0.0155	CbGeAlD
Brompheniramine—CHRM5—central nervous system—schizophrenia	0.001	0.0153	CbGeAlD
Brompheniramine—CHRM3—telencephalon—schizophrenia	0.000984	0.015	CbGeAlD
Brompheniramine—Orphenadrine—GRIN2D—schizophrenia	0.000971	0.133	CrCbGaD
Brompheniramine—KCNH2—forebrain—schizophrenia	0.000949	0.0145	CbGeAlD
Brompheniramine—KCNH2—telencephalon—schizophrenia	0.000873	0.0133	CbGeAlD
Brompheniramine—CHRM5—brain—schizophrenia	0.000794	0.0121	CbGeAlD
Brompheniramine—CHRM2—endocrine gland—schizophrenia	0.000762	0.0116	CbGeAlD
Brompheniramine—HRH1—forebrain—schizophrenia	0.000761	0.0116	CbGeAlD
Brompheniramine—Doxylamine—CHRM1—schizophrenia	0.000755	0.104	CrCbGaD
Brompheniramine—CHRM2—nervous system—schizophrenia	0.000713	0.0109	CbGeAlD
Brompheniramine—Captodiame—DRD3—schizophrenia	0.000708	0.0972	CrCbGaD
Brompheniramine—HRH1—telencephalon—schizophrenia	0.0007	0.0107	CbGeAlD
Brompheniramine—CHRM1—endocrine gland—schizophrenia	0.000694	0.0106	CbGeAlD
Brompheniramine—CHRM2—central nervous system—schizophrenia	0.000687	0.0105	CbGeAlD
Brompheniramine—CYP2E1—telencephalon—schizophrenia	0.000672	0.0103	CbGeAlD
Brompheniramine—CYP2C19—blood—schizophrenia	0.000665	0.0102	CbGeAlD
Brompheniramine—Orphenadrine—GRIN1—schizophrenia	0.000656	0.0901	CrCbGaD
Brompheniramine—CHRM1—nervous system—schizophrenia	0.000649	0.00991	CbGeAlD
Brompheniramine—KCNH2—blood—schizophrenia	0.000635	0.00969	CbGeAlD
Brompheniramine—KCNH2—midbrain—schizophrenia	0.000627	0.00956	CbGeAlD
Brompheniramine—CHRM1—central nervous system—schizophrenia	0.000625	0.00954	CbGeAlD
Brompheniramine—CHRM3—endocrine gland—schizophrenia	0.000621	0.00947	CbGeAlD
Brompheniramine—CYP2B6—gonad—schizophrenia	0.000598	0.00912	CbGeAlD
Brompheniramine—Captodiame—HTR2C—schizophrenia	0.000594	0.0817	CrCbGaD
Brompheniramine—CHRM3—nervous system—schizophrenia	0.000581	0.00887	CbGeAlD
Brompheniramine—CYP2C8—blood—schizophrenia	0.000581	0.00886	CbGeAlD
Brompheniramine—CYP2D6—forebrain—schizophrenia	0.000579	0.00883	CbGeAlD
Brompheniramine—CYP2C19—endocrine gland—schizophrenia	0.000577	0.00881	CbGeAlD
Brompheniramine—Tolterodine—CHRM1—schizophrenia	0.000572	0.0786	CrCbGaD
Brompheniramine—CHRM3—central nervous system—schizophrenia	0.000559	0.00854	CbGeAlD
Brompheniramine—KCNH2—endocrine gland—schizophrenia	0.000551	0.0084	CbGeAlD
Brompheniramine—CHRM2—brain—schizophrenia	0.000545	0.00832	CbGeAlD
Brompheniramine—CYP2D6—telencephalon—schizophrenia	0.000532	0.00812	CbGeAlD
Brompheniramine—CYP2B6—blood—schizophrenia	0.000521	0.00795	CbGeAlD
Brompheniramine—CYP2C9—blood—schizophrenia	0.000516	0.00787	CbGeAlD
Brompheniramine—KCNH2—nervous system—schizophrenia	0.000515	0.00786	CbGeAlD
Brompheniramine—CYP2C8—endocrine gland—schizophrenia	0.000504	0.00769	CbGeAlD
Brompheniramine—CHRM1—brain—schizophrenia	0.000496	0.00757	CbGeAlD
Brompheniramine—KCNH2—central nervous system—schizophrenia	0.000496	0.00757	CbGeAlD
Brompheniramine—CYP2E1—blood—schizophrenia	0.000489	0.00746	CbGeAlD
Brompheniramine—KCNH2—cerebellum—schizophrenia	0.000485	0.0074	CbGeAlD
Brompheniramine—CYP2B6—endocrine gland—schizophrenia	0.000452	0.00689	CbGeAlD
Brompheniramine—CYP2C9—endocrine gland—schizophrenia	0.000447	0.00683	CbGeAlD
Brompheniramine—CHRM3—brain—schizophrenia	0.000444	0.00678	CbGeAlD
Brompheniramine—HRH1—endocrine gland—schizophrenia	0.000441	0.00673	CbGeAlD
Brompheniramine—CYP2E1—endocrine gland—schizophrenia	0.000424	0.00647	CbGeAlD
Brompheniramine—CYP2B6—nervous system—schizophrenia	0.000423	0.00645	CbGeAlD
Brompheniramine—HRH1—nervous system—schizophrenia	0.000413	0.0063	CbGeAlD
Brompheniramine—CYP2B6—central nervous system—schizophrenia	0.000407	0.00621	CbGeAlD
Brompheniramine—HRH1—central nervous system—schizophrenia	0.000398	0.00607	CbGeAlD
Brompheniramine—CYP2E1—nervous system—schizophrenia	0.000397	0.00606	CbGeAlD
Brompheniramine—KCNH2—brain—schizophrenia	0.000394	0.00601	CbGeAlD
Brompheniramine—CYP3A4—blood—schizophrenia	0.000393	0.006	CbGeAlD
Brompheniramine—CYP2D6—blood—schizophrenia	0.000387	0.00591	CbGeAlD
Brompheniramine—CYP2E1—central nervous system—schizophrenia	0.000382	0.00583	CbGeAlD
Brompheniramine—CYP2E1—cerebellum—schizophrenia	0.000373	0.0057	CbGeAlD
Brompheniramine—CYP2C8—brain—schizophrenia	0.00036	0.0055	CbGeAlD
Brompheniramine—CYP3A4—endocrine gland—schizophrenia	0.000341	0.00521	CbGeAlD
Brompheniramine—CYP2D6—endocrine gland—schizophrenia	0.000336	0.00512	CbGeAlD
Brompheniramine—CYP2B6—brain—schizophrenia	0.000323	0.00493	CbGeAlD
Brompheniramine—CYP3A4—nervous system—schizophrenia	0.000319	0.00487	CbGeAlD
Brompheniramine—HRH1—brain—schizophrenia	0.000316	0.00482	CbGeAlD
Brompheniramine—CYP2D6—nervous system—schizophrenia	0.000314	0.00479	CbGeAlD
Brompheniramine—CYP3A4—central nervous system—schizophrenia	0.000307	0.00469	CbGeAlD
Brompheniramine—CYP2E1—brain—schizophrenia	0.000303	0.00463	CbGeAlD
Brompheniramine—CYP2D6—central nervous system—schizophrenia	0.000303	0.00462	CbGeAlD
Brompheniramine—Chlorphenamine—SLC6A3—schizophrenia	0.000297	0.0408	CrCbGaD
Brompheniramine—CYP2D6—cerebellum—schizophrenia	0.000296	0.00451	CbGeAlD
Brompheniramine—Mepyramine—CYP2D6—schizophrenia	0.00029	0.0398	CrCbGaD
Brompheniramine—Tripelennamine—CYP2D6—schizophrenia	0.000268	0.0369	CrCbGaD
Brompheniramine—Promazine—CHRM1—schizophrenia	0.000244	0.0336	CrCbGaD
Brompheniramine—CYP2D6—brain—schizophrenia	0.00024	0.00366	CbGeAlD
Brompheniramine—Chlorphenamine—SLC6A4—schizophrenia	0.000222	0.0305	CrCbGaD
Brompheniramine—Promazine—DRD4—schizophrenia	0.000216	0.0297	CrCbGaD
Brompheniramine—Tolterodine—CYP2D6—schizophrenia	0.000214	0.0294	CrCbGaD
Brompheniramine—Carbinoxamine—CYP2D6—schizophrenia	0.000183	0.0252	CrCbGaD
Brompheniramine—Promazine—DRD1—schizophrenia	0.000183	0.0252	CrCbGaD
Brompheniramine—Promazine—HTR2C—schizophrenia	0.000157	0.0215	CrCbGaD
Brompheniramine—Chlorphenamine—CYP2D6—schizophrenia	0.000156	0.0214	CrCbGaD
Brompheniramine—Diphenhydramine—CYP1A2—schizophrenia	0.000137	0.0188	CrCbGaD
Brompheniramine—Promazine—DRD2—schizophrenia	0.000129	0.0178	CrCbGaD
Brompheniramine—Promazine—CYP1A2—schizophrenia	0.000118	0.0163	CrCbGaD
Brompheniramine—Diphenhydramine—CYP2D6—schizophrenia	0.000106	0.0145	CrCbGaD
Brompheniramine—Promazine—HTR2A—schizophrenia	9.98e-05	0.0137	CrCbGaD
Brompheniramine—CHRM2—Signaling Pathways—DRD4—schizophrenia	1.08e-05	5.91e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CYP1A2—schizophrenia	1.08e-05	5.9e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—YWHAZ—schizophrenia	1.08e-05	5.89e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GAPDH—schizophrenia	1.08e-05	5.88e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GAPDH—schizophrenia	1.07e-05	5.82e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CLOCK—schizophrenia	1.07e-05	5.82e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—TH—schizophrenia	1.07e-05	5.82e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HTR2A—schizophrenia	1.06e-05	5.79e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CYP1A2—schizophrenia	1.06e-05	5.78e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CLOCK—schizophrenia	1.06e-05	5.77e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ERBB3—schizophrenia	1.06e-05	5.76e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—schizophrenia	1.06e-05	5.76e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—COMT—schizophrenia	1.06e-05	5.75e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CNR1—schizophrenia	1.05e-05	5.73e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GSTP1—schizophrenia	1.05e-05	5.72e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CNR1—schizophrenia	1.05e-05	5.71e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—MAOA—schizophrenia	1.05e-05	5.71e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—TH—schizophrenia	1.05e-05	5.7e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CNR1—schizophrenia	1.05e-05	5.69e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	1.05e-05	5.69e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—TPH2—schizophrenia	1.04e-05	5.67e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CACNB2—schizophrenia	1.04e-05	5.67e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CACNA1C—schizophrenia	1.04e-05	5.64e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CNR1—schizophrenia	1.04e-05	5.64e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—TPH2—schizophrenia	1.03e-05	5.63e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CACNB2—schizophrenia	1.03e-05	5.63e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HTR7—schizophrenia	1.03e-05	5.59e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—DRD2—schizophrenia	1.03e-05	5.59e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—DPYD—schizophrenia	1.03e-05	5.58e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HTR7—schizophrenia	1.02e-05	5.57e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—DRD2—schizophrenia	1.02e-05	5.57e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—DRD2—schizophrenia	1.02e-05	5.56e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HTR7—schizophrenia	1.02e-05	5.56e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HTR2A—schizophrenia	1.02e-05	5.54e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—DPYD—schizophrenia	1.02e-05	5.53e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CYP2D6—schizophrenia	1.02e-05	5.53e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—SNAP25—schizophrenia	1.02e-05	5.53e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—DRD2—schizophrenia	1.01e-05	5.5e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HTR7—schizophrenia	1.01e-05	5.5e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3C2A—schizophrenia	1.01e-05	5.5e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP26B1—schizophrenia	1.01e-05	5.49e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ABCB1—schizophrenia	9.95e-06	5.42e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—APOE—schizophrenia	9.89e-06	5.38e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—APOA1—schizophrenia	9.77e-06	5.32e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PRL—schizophrenia	9.7e-06	5.28e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PRL—schizophrenia	9.67e-06	5.26e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PLA2G4A—schizophrenia	9.66e-06	5.26e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GSTM1—schizophrenia	9.66e-06	5.26e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PRL—schizophrenia	9.64e-06	5.25e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PRL—schizophrenia	9.55e-06	5.2e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CACNA1C—schizophrenia	9.53e-06	5.19e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—APOE—schizophrenia	9.47e-06	5.15e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CACNA1C—schizophrenia	9.45e-06	5.14e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ESR1—schizophrenia	9.44e-06	5.14e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—APOA1—schizophrenia	9.36e-06	5.1e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3C2A—schizophrenia	9.29e-06	5.06e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3C2A—schizophrenia	9.21e-06	5.01e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CYP1A2—schizophrenia	9.18e-06	5e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—COMT—schizophrenia	9.09e-06	4.95e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CYP2D6—schizophrenia	9.06e-06	4.93e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—SNAP25—schizophrenia	9.06e-06	4.93e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—TH—schizophrenia	9.05e-06	4.92e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GSTP1—schizophrenia	9.04e-06	4.92e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—S100B—schizophrenia	9.04e-06	4.92e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ESR1—schizophrenia	9.04e-06	4.92e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—MAOA—schizophrenia	9.02e-06	4.91e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—S100B—schizophrenia	9.01e-06	4.91e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TPH1—schizophrenia	8.99e-06	4.9e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GCLM—schizophrenia	8.99e-06	4.9e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—S100B—schizophrenia	8.98e-06	4.89e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—COMT—schizophrenia	8.9e-06	4.84e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—S100B—schizophrenia	8.9e-06	4.84e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GSTP1—schizophrenia	8.86e-06	4.82e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—MAOA—schizophrenia	8.84e-06	4.81e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ERBB4—schizophrenia	8.65e-06	4.71e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ERBB4—schizophrenia	8.62e-06	4.69e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ERBB4—schizophrenia	8.59e-06	4.68e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—GSK3B—schizophrenia	8.56e-06	4.66e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ABCB1—schizophrenia	8.56e-06	4.66e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—MTHFR—schizophrenia	8.54e-06	4.65e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ERBB4—schizophrenia	8.51e-06	4.63e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PRKD1—schizophrenia	8.45e-06	4.6e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ABCB1—schizophrenia	8.38e-06	4.56e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—SNAP25—schizophrenia	8.33e-06	4.54e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PLA2G4A—schizophrenia	8.31e-06	4.52e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GSTM1—schizophrenia	8.31e-06	4.52e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CYP2D6—schizophrenia	8.26e-06	4.5e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—SNAP25—schizophrenia	8.26e-06	4.5e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—GSK3B—schizophrenia	8.2e-06	4.46e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CYP1A2—schizophrenia	8.19e-06	4.46e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PLA2G4A—schizophrenia	8.14e-06	4.43e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GSTM1—schizophrenia	8.14e-06	4.43e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PLA2G4A—schizophrenia	8.13e-06	4.43e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PLA2G4A—schizophrenia	8.1e-06	4.41e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PLA2G4A—schizophrenia	8.08e-06	4.4e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—TH—schizophrenia	8.08e-06	4.4e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PLA2G4A—schizophrenia	8e-06	4.35e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NRG1—schizophrenia	7.98e-06	4.34e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NRG1—schizophrenia	7.95e-06	4.33e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—APOE—schizophrenia	7.95e-06	4.33e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NRG1—schizophrenia	7.93e-06	4.32e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MEF2C—schizophrenia	7.91e-06	4.3e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MEF2C—schizophrenia	7.88e-06	4.29e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MEF2C—schizophrenia	7.86e-06	4.28e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—APOA1—schizophrenia	7.86e-06	4.28e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NRG1—schizophrenia	7.85e-06	4.27e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MEF2C—schizophrenia	7.78e-06	4.24e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—COMT—schizophrenia	7.69e-06	4.19e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GSTP1—schizophrenia	7.66e-06	4.17e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—YWHAZ—schizophrenia	7.64e-06	4.16e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—MAOA—schizophrenia	7.64e-06	4.16e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—YWHAZ—schizophrenia	7.62e-06	4.15e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—YWHAZ—schizophrenia	7.59e-06	4.13e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CYP1A2—schizophrenia	7.54e-06	4.1e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—YWHAZ—schizophrenia	7.52e-06	4.09e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ERBB3—schizophrenia	7.48e-06	4.07e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CYP1A2—schizophrenia	7.47e-06	4.07e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ERBB3—schizophrenia	7.45e-06	4.06e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ERBB3—schizophrenia	7.43e-06	4.04e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—TH—schizophrenia	7.43e-06	4.04e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—schizophrenia	7.41e-06	4.03e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—TH—schizophrenia	7.36e-06	4.01e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ERBB3—schizophrenia	7.36e-06	4e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—MTHFR—schizophrenia	7.34e-06	4e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ABCB1—schizophrenia	7.25e-06	3.95e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HTR2A—schizophrenia	7.19e-06	3.92e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—MTHFR—schizophrenia	7.19e-06	3.92e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HTR2A—schizophrenia	7.17e-06	3.9e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HTR2A—schizophrenia	7.15e-06	3.89e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HTR2A—schizophrenia	7.08e-06	3.85e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GAPDH—schizophrenia	7.06e-06	3.84e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PLA2G4A—schizophrenia	7.04e-06	3.83e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GSTM1—schizophrenia	7.04e-06	3.83e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CLOCK—schizophrenia	6.99e-06	3.81e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—COMT—schizophrenia	6.87e-06	3.74e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—APOE—schizophrenia	6.84e-06	3.72e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GSTP1—schizophrenia	6.83e-06	3.72e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—MAOA—schizophrenia	6.82e-06	3.71e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TPH2—schizophrenia	6.81e-06	3.71e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CACNB2—schizophrenia	6.81e-06	3.71e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—APOA1—schizophrenia	6.76e-06	3.68e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—DPYD—schizophrenia	6.7e-06	3.65e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—APOE—schizophrenia	6.7e-06	3.65e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—APOE—schizophrenia	6.69e-06	3.64e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—APOE—schizophrenia	6.67e-06	3.63e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—APOE—schizophrenia	6.65e-06	3.62e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—APOA1—schizophrenia	6.62e-06	3.6e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—APOA1—schizophrenia	6.61e-06	3.6e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—schizophrenia	6.61e-06	3.6e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—APOA1—schizophrenia	6.59e-06	3.59e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—APOE—schizophrenia	6.58e-06	3.58e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—APOA1—schizophrenia	6.57e-06	3.58e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—APOA1—schizophrenia	6.51e-06	3.54e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ABCB1—schizophrenia	6.47e-06	3.52e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ESR1—schizophrenia	6.39e-06	3.48e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ESR1—schizophrenia	6.37e-06	3.46e-05	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—AKT1—schizophrenia	6.35e-06	3.46e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ESR1—schizophrenia	6.34e-06	3.45e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—COMT—schizophrenia	6.32e-06	3.44e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GSTP1—schizophrenia	6.29e-06	3.42e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ESR1—schizophrenia	6.28e-06	3.42e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GSTM1—schizophrenia	6.28e-06	3.42e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PLA2G4A—schizophrenia	6.28e-06	3.42e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—MAOA—schizophrenia	6.27e-06	3.41e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—COMT—schizophrenia	6.26e-06	3.41e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CACNA1C—schizophrenia	6.23e-06	3.39e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GSTP1—schizophrenia	6.23e-06	3.39e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—MTHFR—schizophrenia	6.22e-06	3.38e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MAOA—schizophrenia	6.22e-06	3.38e-05	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—AKT1—schizophrenia	6.08e-06	3.31e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3C2A—schizophrenia	6.07e-06	3.31e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	6.03e-06	3.28e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ABCB1—schizophrenia	5.95e-06	3.24e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ABCB1—schizophrenia	5.9e-06	3.21e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—GSK3B—schizophrenia	5.79e-06	3.15e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—APOE—schizophrenia	5.79e-06	3.15e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PLA2G4A—schizophrenia	5.78e-06	3.14e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GSTM1—schizophrenia	5.78e-06	3.14e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—GSK3B—schizophrenia	5.77e-06	3.14e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—AKT1—schizophrenia	5.76e-06	3.14e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—GSK3B—schizophrenia	5.76e-06	3.13e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GSTM1—schizophrenia	5.73e-06	3.12e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PLA2G4A—schizophrenia	5.73e-06	3.12e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—APOA1—schizophrenia	5.72e-06	3.12e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—GSK3B—schizophrenia	5.7e-06	3.1e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EP300—schizophrenia	5.63e-06	3.07e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—MTHFR—schizophrenia	5.55e-06	3.02e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—AKT1—schizophrenia	5.52e-06	3e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SNAP25—schizophrenia	5.45e-06	2.97e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP2D6—schizophrenia	5.45e-06	2.97e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EP300—schizophrenia	5.4e-06	2.94e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—APOE—schizophrenia	5.17e-06	2.81e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—APOA1—schizophrenia	5.11e-06	2.78e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—MTHFR—schizophrenia	5.1e-06	2.78e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MTHFR—schizophrenia	5.06e-06	2.75e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP1A2—schizophrenia	4.93e-06	2.68e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TH—schizophrenia	4.86e-06	2.64e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—APOE—schizophrenia	4.75e-06	2.59e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—APOE—schizophrenia	4.71e-06	2.56e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—APOA1—schizophrenia	4.7e-06	2.56e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—APOA1—schizophrenia	4.66e-06	2.54e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—EP300—schizophrenia	4.53e-06	2.47e-05	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—AKT1—schizophrenia	4.29e-06	2.34e-05	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—AKT1—schizophrenia	4.28e-06	2.33e-05	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—AKT1—schizophrenia	4.27e-06	2.32e-05	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—AKT1—schizophrenia	4.22e-06	2.3e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—COMT—schizophrenia	4.13e-06	2.25e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTP1—schizophrenia	4.11e-06	2.24e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MAOA—schizophrenia	4.1e-06	2.23e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—schizophrenia	4.03e-06	2.2e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—AKT1—schizophrenia	3.9e-06	2.12e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—EP300—schizophrenia	3.9e-06	2.12e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ABCB1—schizophrenia	3.89e-06	2.12e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—AKT1—schizophrenia	3.89e-06	2.12e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—AKT1—schizophrenia	3.87e-06	2.11e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—schizophrenia	3.86e-06	2.1e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—AKT1—schizophrenia	3.84e-06	2.09e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—EP300—schizophrenia	3.82e-06	2.08e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EP300—schizophrenia	3.81e-06	2.07e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EP300—schizophrenia	3.8e-06	2.07e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EP300—schizophrenia	3.79e-06	2.06e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PLA2G4A—schizophrenia	3.78e-06	2.06e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTM1—schizophrenia	3.78e-06	2.06e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EP300—schizophrenia	3.75e-06	2.04e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—AKT1—schizophrenia	3.41e-06	1.85e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MTHFR—schizophrenia	3.34e-06	1.82e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—EP300—schizophrenia	3.3e-06	1.8e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—AKT1—schizophrenia	3.26e-06	1.78e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—APOE—schizophrenia	3.11e-06	1.69e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—APOA1—schizophrenia	3.07e-06	1.67e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—EP300—schizophrenia	2.94e-06	1.6e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—AKT1—schizophrenia	2.74e-06	1.49e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—schizophrenia	2.73e-06	1.48e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—schizophrenia	2.72e-06	1.48e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—schizophrenia	2.71e-06	1.48e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—EP300—schizophrenia	2.71e-06	1.47e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—EP300—schizophrenia	2.68e-06	1.46e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—schizophrenia	2.68e-06	1.46e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—AKT1—schizophrenia	2.35e-06	1.28e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—AKT1—schizophrenia	2.31e-06	1.26e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—AKT1—schizophrenia	2.3e-06	1.25e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—AKT1—schizophrenia	2.3e-06	1.25e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—AKT1—schizophrenia	2.29e-06	1.25e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—AKT1—schizophrenia	2.27e-06	1.23e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—AKT1—schizophrenia	1.99e-06	1.09e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AKT1—schizophrenia	1.78e-06	9.69e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—EP300—schizophrenia	1.77e-06	9.64e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AKT1—schizophrenia	1.64e-06	8.91e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AKT1—schizophrenia	1.62e-06	8.83e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AKT1—schizophrenia	1.07e-06	5.82e-06	CbGpPWpGaD
